--2024/Q4-- / 7.695B--
Oct 30, 20242024/Q38.012B / 8.007B--
Jul 31, 20242024/Q27.884B / 7.493B--
May 1, 20242024/Q17.363B / 7.060B--
--2023/Q48.052B / 7.621B--
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 35.863
- -1.157-3.13%
Trading Nov 6 10:11 ET
73.17BMarket Cap22.65P/E (TTM)
36.110High35.625Low2.07MVolume35.930Open37.020Pre Close74.16MTurnover0.11%Turnover Ratio11.47P/E (Static)2.04BShares45.36052wk High4.00P/B70.84BFloat Cap33.04252wk Low1.60Dividend TTM1.98BShs Float45.360Historical High4.46%Div YieldTTM1.31%Amplitude6.446Historical Low35.831Avg Price1Lot Size
GlaxoSmithKline Key Stats
GlaxoSmithKline Q3 2024 Earnings Date
Currency：GBPOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 8.01B | 8.01B | +5.14M |
| Beat Est. | -1.72% | -1.66% | +0.06% |
| EPS | 0.12 | -0.03 | -0.14 |
| Miss Est. | -84.82% | -103.93% | -124.05% |
Analyst Rating
Nov 5, 2024
GlaxoSmithKline Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
GlaxoSmithKline Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
